Gain Therapeutics (GANX) Institutional Ownership $1.66 -0.06 (-3.49%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)CurrentInstitutional OwnershipPercentage11.97%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$737.67KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$32.69K Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GANX Institutional Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Gain Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC271,972$484K0.0%+48.0%1.065% 8/9/2024 Renaissance Technologies LLC118,700$152K0.0%+154.2%0.658% 8/9/2024 Warberg Asset Management LLC51,600$66K0.0%N/A0.286% 8/3/2024 Hohimer Wealth Management LLC330,000$422K0.1%N/A1.828% 1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184% 7/25/2023Raymond James & Associates33,400$150K0.0%+67.0%0.271% Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023 CM Management LLC90,000$434K0.5%-18.2%0.740% 5/2/2023Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105% 4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168% 2/9/2023 CM Management LLC110,000$344K0.4%-12.0%0.926% 1/17/2023Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158% 11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263% 10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202% 10/12/2022Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210% 5/9/2022 CM Management LLC125,000$511K0.4%+38.9%1.052% 2/3/2022 Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085% 2/2/2022 CM Management LLC90,000$489K0.4%+39.9%0.758% 11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810% 11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211% 11/9/2021 Indie Asset Partners LLC29,652$221K0.2%N/A0.250% 11/8/2021 CM Management LLC64,327$479K0.4%+543.3%0.542% 8/17/2021 Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421% 8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255% 8/11/2021 Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025% 8/10/2021 CM Management LLC10,000$100K0.1%N/A0.084% 5/27/2021 Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/19/2021 Worth Venture Partners LLC15,532$232K0.1%N/A0.131% 5/18/2021 Millennium Management LLC14,367$214K0.0%N/A0.121% 5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602% 5/18/2021 Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/18/2021 Jane Street Group LLC22,754$339K0.0%N/A0.192% (Data available from 1/1/2016 forward) GANX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GANX shares? During the previous two years, the following institutional investors and hedge funds held shares of Gain Therapeutics shares: Geode Capital Management LLC ($484K), CM Management LLC ($434K), Hohimer Wealth Management LLC ($422K), Renaissance Technologies LLC ($152K), Raymond James & Associates ($78K), and Warberg Asset Management LLC ($66K), and Wealth Alliance Advisory Group LLC ($60K).Learn more on GANX's institutional investors. What percentage of Gain Therapeutics stock is owned by institutional investors? 11.97% of Gain Therapeutics stock is owned by institutional investors. Learn more on GANX's institutional investor holdings. Which institutional investors have been buying Gain Therapeutics stock? The following institutional investors have purchased Gain Therapeutics stock in the last 24 months: Hohimer Wealth Management LLC ($330K), Geode Capital Management LLC ($88.24K), Renaissance Technologies LLC ($72K), Warberg Asset Management LLC ($51.60K), and Raymond James & Associates ($13.40K). How much institutional buying is happening at Gain Therapeutics? Institutional investors have bought a total of 555,236 shares in the last 24 months. This purchase volume represents approximately $797.70K in transactions. Which Gain Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Gain Therapeutics stock in the last 24 months: CM Management LLC ($35K), Raymond James & Associates ($14.01K), and Wealth Alliance Advisory Group LLC ($12.50K). How much institutional selling is happening at Gain Therapeutics? Institutional investors have sold a total of 61,510 shares in the last 24 months. This volume of shares sold represents approximately $245.00K in transactions. Related Companies Hookipa Pharma Major Shareholders Passage Bio Major Shareholders X4 Pharmaceuticals Major Shareholders Heron Therapeutics Major Shareholders Inozyme Pharma Major Shareholders Caribou Biosciences Major Shareholders Tenaya Therapeutics Major Shareholders Nanobiotix Major Shareholders Kyverna Therapeutics Major Shareholders scPharmaceuticals Major Shareholders This page (NASDAQ:GANX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gain Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
